{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1234.75","meta":{"versionId":"6","lastUpdated":"2022-01-06T01:02:20.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.75","version":"20220106","name":"COVID19 vaccine ICD10PCS codes for exposure identification","status":"active","date":"2022-01-06T01:02:20-05:00","publisher":"BEST System Steward","compose":{"include":[{"system":"http://www.icd10data.com/icd10pcs","version":"2022","concept":[{"code":"XW013S6","display":"Introduction of COVID-19 Vaccine Dose 1 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"},{"code":"XW013T6","display":"Introduction of COVID-19 Vaccine Dose 2 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"},{"code":"XW013U6","display":"Introduction of COVID-19 Vaccine into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"},{"code":"XW023S6","display":"Introduction of COVID-19 Vaccine Dose 1 into Muscle, Percutaneous Approach, New Technology Group 6"},{"code":"XW023T6","display":"Introduction of COVID-19 Vaccine Dose 2 into Muscle, Percutaneous Approach, New Technology Group 6"},{"code":"XW023U6","display":"Introduction of COVID-19 Vaccine into Muscle, Percutaneous Approach, New Technology Group 6"}]}]},"expansion":{"identifier":"urn:uuid:2a0abdd6-9f39-4ba0-a862-4223b10c4e3a","timestamp":"2022-06-10T06:39:23-04:00","total":6,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"XW013S6","display":"Introduction of COVID-19 Vaccine Dose 1 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"XW013T6","display":"Introduction of COVID-19 Vaccine Dose 2 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"XW013U6","display":"Introduction of COVID-19 Vaccine into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"XW023S6","display":"Introduction of COVID-19 Vaccine Dose 1 into Muscle, Percutaneous Approach, New Technology Group 6"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"XW023T6","display":"Introduction of COVID-19 Vaccine Dose 2 into Muscle, Percutaneous Approach, New Technology Group 6"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"XW023U6","display":"Introduction of COVID-19 Vaccine into Muscle, Percutaneous Approach, New Technology Group 6"}]}}